Noise-Induced Hearing Loss: Translating Risk from Animal Models to Real-World Environments
Noise-induced hearing loss (NIHL) is one of the most common injuries for Service members and civilian workers exposed to noise. Increased knowledge of the cellular and molecular events in the inner ear after noise exposure have stimulated research into the potential for pharmaceutical prevention of NIHL. This Special Issue contains contributions focused on the methods and models used during preclinical assessment of investigational new drug agents for potential otoprotective benefits, and information about human populations at risk for NIHL. At this time, there are no drugs approved by the FDA for the prevention of NIHL.
Guest Editors: Colleen G. Le Prell, CAPT William J. Murphy, Tanisha L. Hammill, and J. R. Stefanson